Danish Study Finds Anti-Viral Paxlovid May Be Triggering Drug-to-Drug Interactions, Particularly in Elderly COVID-19 Patients

Oct 14, 2022 | International Laboratory News, Laboratory Pathology, Laboratory Resources, Laboratory Testing

These findings may be useful to clinical laboratory professionals when physicians want guidance in effective treatments for COVID-19 patients, particularly when there are concerns about a rebound of the infection Drug interactions are a major concern for physicians and clinical laboratories. That is especially true given the push for nearly universal COVID-19 vaccinations and boosters. Now, a study conducted in Denmark may show that the use of Paxlovid as an antiviral drug to treat early...
;